Cognitive Behavioral Therapy for Chronic Pain in Veterans with Serious Mental Illness
Official title: Exploring the Efficacy of Cognitive Behavioral Therapy for Chronic Pain in Veterans With Serious Mental Illness
Run by VA Office of Research and Development · NCT06758414 · Data updated 2026-11-12
This study will test whether Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) helps Veterans with serious mental illness and chronic low back pain reduce pain-related interference and improve quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 190 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | September 30, 2029 |
| Study ends | September 30, 2029 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT06758414 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Veterans aged 18 or older who are enrolled in outpatient programming at a VISN 5 VA facility, have a documented SMI diagnosis and chronic low back musculoskeletal pain with a PEG-3 score of 4 or higher, have regular telephone access, and have capacity to consent are the intended participants.
✕Probably not a fit
Patients actively using moderate-to-severe substances, those who have received individual CBT-CP within the past 12 months, or those with acute pain conditions or limited mobility that prevent participation are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll about 190 Veterans with serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression with psychosis) and chronic low back musculoskeletal pain and randomize them to CBT-CP or an active Health & Wellness control. Treatments are delivered within the VA setting and outcomes are measured at baseline, immediately post-treatment, and six months post-treatment using standardized assessments of pain-related functioning, pain severity, and quality of life. The study will also examine how changes in pain relate to psychiatric symptoms over time. Participants must meet a PEG-3 threshold and be enrolled in outpatient programming within VISN 5.
Why it matters
Potential benefit: If successful, CBT-CP could offer a non-drug treatment that reduces pain interference and improves functioning and quality of life for Veterans with serious mental illness.
How similar studies have gone: CBT-CP is an established, evidence-based nonpharmacological treatment for chronic pain in general and in VA populations, but few randomized trials have tested its effectiveness specifically in people with serious mental illness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have chronic back pain, per medical record * Have a PEG-3 rating of 4 or greater for pain severity or interference * Meet criteria for an SMI diagnosis (schizophrenia, schizoaffective disorder, bipolar disorder, major depression with psychosis) per medical record * 18 years of age or older * Enrolled in outpatient programming within a VISN 5 health care facility at time of consent * Have regular access to a telephone * Capacity to sign informed consent Exclusion Criteria: * Are engaging in moderate-to-severe substance use that would impact their ability to participate and/or would require a higher level of care (as determined by treating provider) * Engagement in individual Cognitive Behavioral Therapy for Chronic Pain (CBT-CP), whether currently or in the past 12 months * Have a current acute pain condition, medical condition, or limited mobility (i.e., unable to walk one city block) that would interfere with their ability to engage in CBT-CP interventions (e.g., activity pacing/walking program)
Where it's running
-
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Letitia Travaglini, PhD — Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
- Study coordinator: Letitia Travaglini, PhD
- Email: Letitia.Travaglini@va.gov
- Phone: (410) 605-1867
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.